Skip to main content
. 2018 Dec 11;18:1364. doi: 10.1186/s12889-018-6235-6

Fig. 2.

Fig. 2

Proportion of children with and without vaccine delays at 2–4-6 and 12 month visits, 2006–2016*. *Both cohorts included. DTaP1 is recommended at 2 months, DTaP2 at 4 months, DTaP3 at 6 months and the first measles-containing vaccine at 12 months